CD86 and lung cancer: Notably, exosomes derived from Rab27a‐overexpressing lung cancer cells not only promote upregulation of MHC class II, CD80, and CD86 on DCs, but also facilitate CD4+ T cell proliferation and type I cytokine secretion, culminating in effective tumor growth inhibition in vivo.